Citius Pharmaceuticals, Inc. (CTXR): Nasdaq/NYSE listing notice — Citius Pharma gets Nasdaq bid-price deficiency notice; 180-day cure period

Citius Pharmaceuticals, Inc.

Nasdaq notified Citius on Sept 12, 2023 that bid price closed below $1.00 for 30 consecutive business days.
Company has until March 11, 2024 to regain compliance; must close at $1.00+ for 10 consecutive days.
If not compliant by March 2024, may be eligible for an additional 180-day period, subject to other listing standards.
Company is evaluating options; no immediate effect on listing under symbol CTXR.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Citius Pharmaceuticals, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 5550(a)(2)

Exact text from the filing

September 12, 2023, Nasdaq Stock Market LLC (“Nasdaq”) notified Citius Pharmaceuticals, Inc. (the “Company”) that for the last 30 consecutive business days, the bid price for the Company’s common stock had closed below the minimum $1.00 per share requirement for continued inclusion on the Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2) (the “Bid Price Rule”). In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company has a compliance period of 180 calendar days, or until March 11, 2024, to regain compliance with the Bid Price Rule. If at any time before March 11, 2024

View on SEC.gov

Browse all listing & compliance notices →

Citius Pharmaceuticals, Inc. filing history →

Source: SEC EDGAR

accession 0001213900-23-077043

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.